Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/3/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Ingmar Hoerr Phd MBA

Wrong Dr. Ingmar Hoerr Phd MBA?

Co-Founder and Chief Executive Of...

Phone: +49 **********  
Email: i***@***.com
Local Address:  Tuebingen , Germany
Company Description: CureVac is an integrated biopharmaceutical company with a pipeline of promising drug candidates. Using its RNA technology platform, CureVac is currently developing...   more

Employment History


  • PhD
    University of Tübingen
  • MBA
    Danube University
  • PhD , biology
    Tuebingen University
  • PhD , biology
    Tübingen University
  • PhD , biochemistry
    Tübingen University
  • MBA
    Danube University of Krems
77 Total References
Web References
Ingmar Hoerr, Ph.D., ..., 3 Nov 2015 [cached]
Ingmar Hoerr, Ph.D., co-founder and CEO of CureVac, added, "The successful financing is an important step for CureVac as it provides the company with the resources needed to further strengthen our preclinical and clinical mRNA pipeline. Management, 18 July 2015 [cached]
Ingmar Hoerr, PhD, MBA Chief Executive Officer
From this key discovery, Ingmar Hoerr and Florian von der Mülbe built up a company that is now a global leader in the research and development of mRNA-based drugs.
Ingmar Hoerr received his PhD from the University of Tübingen and his MBA from Danube University, Krems, Austria.
Florian worked with Biotest GmbH and Roche AG before joining CureVac in 2000 - working with Ingmar Hoerr to build the business from the start.
As such, our U.S. office will ..., 10 Sept 2015 [cached]
As such, our U.S. office will provide an important base for CureVac to extend our U.S. interest, while enhancing our development capabilities, particularly those targeting mRNA-based prophylactic vaccines,� Ingmar Hoerr, chief executive officer of CureVac said in a statement.
Ingmar Hoerr, Ph.D., ..., 3 Sept 2015 [cached]
Ingmar Hoerr, Ph.D., co-founder and CEO of CureVac, will provide an overview of the company's business, industry-leading mRNA technology platform, and clinical-stage development pipeline during his presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. Company, 18 July 2015 [cached]
In the late 1990s, Dr. Ingmar Hoerr, Co-founder and CEO of CureVac GmbH, made an unexpected discovery during his doctoral research in biology, which was contrary to the established scientific belief at the time: RNA, which was generally thought to be a very unstable biomolecule, could be administered directly into tissue as a therapeutic vaccine or agent once the biological properties of the molecule were appropriately modified. Furthermore, complicated formulations or molecular packaging were not required to achieve these results.
This discovery led to a new fundamental understanding of the potential of RNA to treat diseases and to generate prophylactic immunity. These fascinating possibilities prompted the company's three founders, Ingmar Hoerr, Steve Pascolo, and Florian von der Mülbe, to found CureVac without investors during the difficult market environment of 2000.
Other People with the name "Hoerr":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.